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Abstract: Diabetes mellitus is a disease characterized by hyperglycemia as well as progressive changes to the 
pancreatic beta cell structure. This study was conducted to determine the antihyperglycemic activity of 
ceplukan herb extract (Physalis angulata L.) in alloxan-induced male Syrian hamsters and high cholesterol 
feed. The study used 24 hamsters divided into six groups. Group I were given a standard diet and regular 
drinking water, Group II were given metformin dose 61,66 mg/kg body weight (BW), Group III were 
alloxan-induced and high cholesterol feed, Groups IV, V and VI were given extract dose 60, 120 and 240 
mg/kg BW respectively. The animals were induced alloxan monohydrate as well as were given high 
cholesterol feed during treatment. Blood sampling was performed on the 29th and 44th day using a clinical 
spectrophotometer. The results show significant differences between treatment groups (α <0,05), followed 
by Tukey test. In conclusion, the preparation of herbal extract test ceplukan at doses of 120 and 240 mg/kg 
BW could reduce blood glucose levels by 50.84% and 43.41% which is equivalent to metformin dose of 
61.66 mg/kg BW with a percentage of 53.12%. 
1 INTRODUCTION 
Diabetes mellitus (DM) is a group of metabolic 
disorders characterized by hyperglycemia and 
abnormalities in carbohydrate, fat, and protein, 
resulting from insulin secretion abnormalities, 
insulin work or both (Dipiro, 2014). Diabetes 
mellitus is divided into two types, namely type I DM 
(5%-10% of cases), which is caused by damaged 
pancreatic β cells suffered by hereditary or genetic 
and type II DM (90% of cases) caused by insulin 
resistance due to increased lipolysis, free fatty acid 
production or increased glucose production in the 
liver (Dipiro, 2015). 
DM in Indonesia is a serious threat to health 
development, can cause blindnesss, kidney failure, 
diabetic feet (gangrene) so it must be amputated, 
heart disease and stroke (Depkes, 2013). The  World 
Health Organization (WHO) Global Status Report 
on NCD in 2010 stated that 60% of the cause of 
death of all ages in the world is due to non-
communicable diseases and DM is ranked 6th as the 
cause of death. Approximately 1.3 million people 
die from diabetes and 4% die before the age of 70 
years. In 2030, it is estimated that DM will be 
ranked 7th as the cause of death worldwide and that 
Indonesia will have 21.3 million people with DM 
(Depkes, 2013). This condition will make Indonesia 
on the 4th position after the United States, China and 
India as countries that have the largest diabetics with 
the largest population in the world (Depkes, 2012). 
One of the medicinal plants that can be used as 
an antidiabetic agent is ceplukan (Physalis angulata 
L.). In West Java, ceplukan has been used as 
diabetes drug (Sutjiatmo et al. 2011). Chemical 
compounds of this plant include alkaloids, 
flavonoids, saponins, fisalin, sterols/terpenes and 
citric acid (Depkes, 1995). Traditionally, this plant 
has been used to treat boils, and diabetes (Depkes, 
1995). 
Previous research has shown that the ethanol 
extract of ceplukan leaves at 100 mg/kg BW can 
reduce blood glucose levels in mice with a 
percentage of 56.34% (Kasali, 2016). In isolation 
research from ethanol extract of ceplukan fruits at 25 
mg/kg BW and 50 mg/kg BW for 15 days can 
decrease rat blood glucose level to 38,75% and 
27,55% respectively (Raju, 2015). Another study has 
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 reported that the fraction of chloroform herb 
ceplukan at a dose of 0,5 mg/20g BW, 1 mg/20g 
BW and 2 mg/20g BW can reduce blood glucose 
levels in mice and the dose 2 mg/20g BW can 
reduce blood glucose levels of mice equally to 
glibenclamid 0,013 mg/20g BW (Sunaryo et al. 
2012).  
2 MATERIALS AND METHODS 
2.1 Materials 
The ingredients used are ceplukan herb (Physalis 
angulata L.). Determination was done at 
“Herbarium Bogoriense” Botani section, Pusat 
Penelitian Biologi - LIPI Cibinong. 
Alloxan monohydrate from Sigma-Aldrich Co., 
USA. Metformin HCL from Sohan Healthcare Pvt 
Ltd, Maharashtra. High cholesterol feed, glucose kit 
reagent was using commercial kits purchased from 
Human Diagnostics Worldwide Germany.  
2.2 Animal Subjects 
The experiment used twenty-four male Syrian 
hamsters (Mesocricetus auratus), aged 3–4 months 
and weighed around 80 g. The animals were housed 
under standard environmental conditions. The study 
protocol was approved by the Health Research 
Ethics Committee of Universitas Muhammadiyah 
Prof. Dr. Hamka, West Jakarta, Indonesian. The 
reference number for approval was 02/18.05/005. 
The animal subjects were acclimatized in a cage 
for approximately one week to adapt to the new 
environment. The animals were divided into 6 
groups consisting of 4 hamsters. 
2.3 Extraction 
One kilogram of ceplukan dried powder (Research 
Institute for Spices and Medicinal 
Plants/BALITTRO, Bogor, Indonesia) was 
macerated with 70% ethanol for 6 hours and was 
stirred occasionally to reveal the active ingredients. 
The mixture was allowed to stand for 18 hours. The 
maceration result was then separated by filtration. 
The reproduction process was repeated three times. 
The maceration result was concentrated with a 
vacuum rotary evaporator until it became a viscous 
extract (Department of Health RI, 2008). The 
concentrated result was put in a water bath at 40–
50oC for one day to obtain an extract with a constant 
weight. 
2.4 Phytochemical Screening 
The phytochemical screening of ceplukan herb 
extract included an examination of alkaloids using 
Bourchardat reagents, testing flavonoids with 
methanol, concentrated HCL and magnesium 
powder. Saponin test were perfomed with foam 
formation, tannin test with FeCl3 1% reagent, and 
Steroid testing with ethanol, concentrated H2SO4 
were done if there is a red or purple color change 
indicating the presence of triterpenoids and the green 
color indicates steroid presence (Depkes, 1995). 
Extract yield was determined by calculating the dry 
extract weight obtained from the weight of dry 
powder before extraction. 
2.5 Category and Animals Subject 
Treatment 
The experiment was done with a complete 
randomized design, using 24 white male, hamsters 
divided into six groups consist of 4 rats. 
a. Group I:  The group was given a standard diet 
and regular drinking water. 
b. Group II: Positive Control, was given alloxan 
monohydrate, high cholesterol feed and 
comparative preparations. 
c. Group III: Negative Control, was given alloxan 
monohydrate, high cholesterol feed and Na-
CMC 0,5%. 
d. Group IV: was given alloxan monohydrate, high 
cholesterol feed and ethanolic herb extract of 
ceplukan dose I. 
e. Group V: was given alloxan monohydrate, high 
cholesterol feed and ethanolic herb extract of 
ceplukan dose II. 
f. Group VI: was given alloxan monohydrate, high 
cholesterol feed and ethanolic herb extract of 
ceplukan dose III. 
2.6 Method of Glucose Levels 
Measurement 
Blood sampling was taken on Day 29 and Day 44; 
hamsters were first anaesthetized using ketamine 
dose 10 mg/kg BW (Lacy et al. 2009). Blood 
collection was performed at the eye orbital sinuses 
after the animals were previously preoccupied for 12 
hours. The blood was taken as much as one mL, and 
was collected in a microtube. The blood was 
centrifuged at 4000 rpm for 15 minutes to obtain the 
serum (Suharmiati, 2003). Serum was taken ten μL, 
was mixed with enzyme reagent (glucose reagent 
kit) 1000 μL, then was homogenized using vortex 
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 for 1 minute and was incubated for 5 minutes at 
370C blood glucose level were tested with a clinical 
photometer (Human, 2012). 
2.7 Data Analysis 
The data using statistical analysis show that the 
decrease in percentage data from the initial and late 
glucose levels, baseline levels are levels after 
alloxan induction and high cholesterol feed while the 
final content levels after treatment. The data were 
tested for normality and homogeneity and were then 
analyzed with one-way ANOVA test with 95% 
significance level (α = 0,05). If there is a significant 
difference, the data were then analyzed with the 
Tukey test (Santosa, 2010). 
3 RESULTS AND DISCUSSION 
Based on the results of the determination, indicating 
that the plant is Physalis angulata L. included in 
Solanaceae. Data extraction of ceplukan herb such 
as weigh ceplukan fresh and dry, weigh of ceplukan 
extrac and extract  yield are given in Table 1. 
Parts of ceplukan that used is the herbaceous 
part. A report by The Department of Health (1995) 
stated that chemical compounds found in ceplukan 
include alkaloids, flavonoids, saponins, fisalin, 
sterols/terpene and citric acid. Alkaloids, flavonoids, 
saponins, and steroids could be obtained by 
phytochemical screening. (Table 2). The results of 
extract quality characteristics showed specific smell, 
thick form and had a drying loss of 9.59% can be 
seen in table 3. 
Metformin was used as a comparative drug in 
this study because it is a first-line antidiabetic drug 
against DM2 patients with a history of obesity. In 
this study, the test animals not only being treatment 
to become hyperglycemia, but also induced to be 
hypercholesterolemia. Then, induction of alloxan 
will damage cells β Langerhans  pancreatic cells to 
inhibit the production of insulin. Therefore 
metformin has a mechanism of increasing peripheral 
tissue sensitivity of insulin (Suharmiati, 2003) and it 
was chosen as a comparative drug preparation in this 
study because the mechanism was aligned with the 
alloxan to correct the damage caused by alloxan. 
Feeding for the hypercholesterolemic hamsters 
was performed for 44 days to maintain the stability 
of cholesterol. On Day 22, alloxan was induced 
intraperitoneally with a dose of 180 mg/kg BW. 
Before blood sample collection, the hamsters were 
fasted for 12 hours to avoid the effect of increased 
glucose level after meal. Measurement of baseline 
blood glucose level of the test animals were 
performed on Day 29 to determine whether the 
induced alloxan had successfully increased the blood 
glucose level. After the level of glucose and 
cholesterol were stated to increase pathologically 
(the level of complication was achieved), then the 
extract was orally administered by using feeding 
tube. The extract was given every morning for 14 
days. On Day 44, the final blood glucose level was 
checked to see whether there is a decrease or not.  
The data of the percentage of decrease of blood 
glucose level was examined by normal distribution 
test {(α = 0,202) > 0,05} and homogeneity test {(α = 
0,104) > 0,05}  which show that the data is normally 
distributed and homogeneous. One-way ANOVA 
test was run to test whether the mean of % decrease 
in the blood glucose level is the same or 
significantly different. The result {(α = 0,000)  < 
0,05} shows that there are significant differences 
between all groups.  Then the one-way ANOVA 
results were further examined with the Tukey test to 




1. Alkaloid + 
2. Saponin + 
3. Tanin - 
4. Flavonoid + 
5. Steroid + 
6. Triterpenoid - 
Note: “+” (positive),  “-“ (negative) 
Table 1: Data extraction results 
No. Type Result
1. Ceplukan Fresh 15 kg
2. Ceplukan Dry 1,5 kg
3. Ceplukan Powder 1,1 kg
4. Macerate of Powder 1 kg
5. Extract 158,86 g
6.  Extract Yield 15,886 %
 
Table 3: Extract characteristics 
No. Type of Test Extract 




2. Flavors 9,59% 
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 know which group has, or has no significant 
difference between normal control, negative control, 
positive control, Dose 1, Dose 2 and Dose 3. 
The-ability to decrease blood glucose is related 
to the biological activity of compounds in ceplukan 
plants. The compounds contained are flavonoids, 
alkaloids, steroids, and saponins. The chemical 
content of steroids can stimulate the release of 
insulin from the pancreas to lower blood glucose 
levels (Sediarso et al. 2008). Insulin will then work 
to increase the transport of glucose from the blood 
into cells by increasing the permeability of the cell 
membrane to glucose. Once inside the cell, glucose 
will then be used to generate energy. The liver and 
muscles will convert glucose into glycogen and will 
then be stored there. This conversion causes the 
blood glucose level in the body decreases slowly 
(Gustina, 2012). 
Figure 1 shows the plasma glucose levels of the 
experimental animals. The highest decrease in blood 
glucose was shown by Dose 2 (120 mg/kg BW) 
which was 50,84% compared to Dose 3 (240 mg/kg 
BW) which was 43,41% and Dose 1 (60 mg/kg BW) 
which was 34,74%. All pharmacologic responses 
must have the maximum effect (Emax), regardless 
of the high concentration that occurs, a point is 
reached when adding the concentration does not 
increase the response (Katzung et al. 2014). This 
occurs in Dose 2 that was smaller than Dose 3, but 
Dose 2 gave a greater decrease effect compared to 
Dose 3, the maximum effect occurred in Dose 2; 
although Dose 3 twice higher. Therefore, this study 
shows that Dose 2 (120 mg/kg BW) has a better 
activity in lowering blood glu  cose by 50,84%. 
4 CONCLUSION 
It can be concluded that ceplukan extract can lower 
blood glucose levels in male hamsters with 
hypercholesterolemia and hyperglycemia. Dose 2 
(120 mg/kg BW) has a better activity in lowering 
blood glucose by 50,84% and equivalent to 
metformin dose 61,66 mg/kg BW which was 
53,12%.  
FUTURE RECOMMENDATION 
The next stage of the research may focus on the 
content of plant compounds and fractionation phase 
as a decrease in blood glucose levels.  
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